Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Human MARF1 is an endoribonuclease that interacts with the DCP1:2 decapping complex and degrades target mRNAs

Open access

Abstract

Meiosis arrest female 1 (MARF1) is a cytoplasmic RNA binding protein that is essential for meiotic progression of mouse oocytes, in part by limiting retrotransposon expression. MARF1 is also expressed in somatic cells and tissues; however, its mechanism of action has yet to be investigated. Human MARF1 contains a NYN-like domain, two RRMs and eight LOTUS domains. Here we provide evidence that MARF1 post-transcriptionally silences targeted mRNAs. MARF1 physically interacts with the DCP1:DCP2 mRNA decapping complex but not with deadenylation machineries. Importantly, we provide a 1.7 Å resolution crystal structure of the human MARF1 NYN domain, which we demonstrate is a bona fide endoribonuclease, the activity of which is essential for the repression of MARF1-targeted mRNAs. Thus, MARF1 post-transcriptionally represses gene expression by serving as both an endoribonuclease and as a platform that recruits the DCP1:DCP2 decapping complex to targeted mRNAs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/nar/gky1011

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. MARF1 interacts with the DCP1:DCP2 mRNA decapping complex. (A) Schematic diagram of full-length MARF1. (B) Dot plot depicting high-confidence protein interactions identified by affinity purification of FLAG-MARF1 in HEK293 cells. SAINT analysis of two independent experiments was performed and a subset of high-confident preys is presented in this dot plot. Node color represents the average spectral counts, and the node edge color corresponds to the SAINTexpress Bayesian FDR value (BFDR). (C) Western blot analysis of lysates derived from HEK293 cells expressing either FLAG-BirA* or FLAG-BirA*-MARF1 and probed with anti-FLAG antibody. (D) Immunoprecipitation (IP) of FLAG-BirA* and FLAG-BirA*-MARF1 from benzonase–treated HEK293 cell extracts using anti-FLAG antibody. Immunoprecipitated complexes were separated by SDS-PAGE and probed with antibodies against the indicated proteins. (E) Streptavidin pulldowns of biotinylated proteins from benzonase-treated lysates outlined in (C). Precipitated proteins were subjected to SDS-PAGE and probed with antibodies against the indicated endogenous proteins. Inputs represent 2% of total lysates.
Figure 1. MARF1 interacts with the DCP1:DCP2 mRNA decapping complex. (A) Schematic diagram of full-length MARF1. (B) Dot plot depicting high-confidence protein interactions identified by affinity purification of FLAG-MARF1 in HEK293 cells. SAINT analysis of two independent experiments was performed and a subset of high-confident preys is presented in this dot plot. Node color represents the average spectral counts, and the node edge color corresponds to the SAINTexpress Bayesian FDR value (BFDR). (C) Western blot analysis of lysates derived from HEK293 cells expressing either FLAG-BirA* or FLAG-BirA*-MARF1 and probed with anti-FLAG antibody. (D) Immunoprecipitation (IP) of FLAG-BirA* and FLAG-BirA*-MARF1 from benzonase–treated HEK293 cell extracts using anti-FLAG antibody. Immunoprecipitated complexes were separated by SDS-PAGE and probed with antibodies against the indicated proteins. (E) Streptavidin pulldowns of biotinylated proteins from benzonase-treated lysates outlined in (C). Precipitated proteins were subjected to SDS-PAGE and probed with antibodies against the indicated endogenous proteins. Inputs represent 2% of total lysates.CC BY · PubMed Central
Figure 2. The DCP1:DCP2 complex interacts with the MARF1 C-terminus. (A) Schematic diagram of full-length MARF1 and MARF1 fragments used in co-precipitation experiments in B through E. Dashed lines indicated the region required for decapping factor association in (E). (B) Western blot analysis of lysates derived from HeLa cells expressing FLAG-tagged MARF1 fragments outlined in (A). (C–E) Immunoprecipitation (IP) of MARF1 fragments outlined in (A) from benzonase–treated HeLa cell extracts using anti-FLAG antibody. Immunoprecipitated complexes were separated by SDS-PAGE and probed with antibodies against the indicated proteins. Inputs represent 2% of lysates.
Figure 2. The DCP1:DCP2 complex interacts with the MARF1 C-terminus. (A) Schematic diagram of full-length MARF1 and MARF1 fragments used in co-precipitation experiments in B through E. Dashed lines indicated the region required for decapping factor association in (E). (B) Western blot analysis of lysates derived from HeLa cells expressing FLAG-tagged MARF1 fragments outlined in (A). (C–E) Immunoprecipitation (IP) of MARF1 fragments outlined in (A) from benzonase–treated HeLa cell extracts using anti-FLAG antibody. Immunoprecipitated complexes were separated by SDS-PAGE and probed with antibodies against the indicated proteins. Inputs represent 2% of lysates.CC BY · PubMed Central
Figure 3. MARF1 NYN domain is required to degrade a target mRNA. (A) Schematic diagram of the basic Renilla luciferase-encoding mRNA reporter, containing five 19-nt BoxB hairpins, interacting with λN-HA-MARF1. (B) Schematic diagram of full-length MARF1 and MARF1 fragments used in tethering assays. (C) Expression levels of λNHA-tagged fusion proteins, as determined by western analysis using anti-HA and anti-actin antibodies. (D) RL activity detected in extracts from HeLa cells expressing the indicated proteins. Cells were cotransfected with constructs expressing the RL-5BoxB reporter, FL, and indicated fusion proteins. Histograms represented normalized mean values of RL activity and mRNA levels from a minimum of three experiments. RL activity values seen in the presence of λNHA-LacZ were set as 100. (E) Representative Northern blot of RL-5BoxB and FL mRNAs levels.
Figure 3. MARF1 NYN domain is required to degrade a target mRNA. (A) Schematic diagram of the basic Renilla luciferase-encoding mRNA reporter, containing five 19-nt BoxB hairpins, interacting with λN-HA-MARF1. (B) Schematic diagram of full-length MARF1 and MARF1 fragments used in tethering assays. (C) Expression levels of λNHA-tagged fusion proteins, as determined by western analysis using anti-HA and anti-actin antibodies. (D) RL activity detected in extracts from HeLa cells expressing the indicated proteins. Cells were cotransfected with constructs expressing the RL-5BoxB reporter, FL, and indicated fusion proteins. Histograms represented normalized mean values of RL activity and mRNA levels from a minimum of three experiments. RL activity values seen in the presence of λNHA-LacZ were set as 100. (E) Representative Northern blot of RL-5BoxB and FL mRNAs levels.CC BY · PubMed Central
Figure 4. Structure of the MARF1 NYN domain. (A) Comparative sequence analysis of the NYN domains of human (Hs), Xenopus tropicalis (Xt), Danio rerio (Dr), Lasius niger (Ha) and Apis mellifera (Am) MARF1 orthologs. The multiple sequence alignment was generated using MAFFT version 7 and formatted using Jalview (49,50). Secondary structure elements with corresponding numbering are indicated above the sequence. Invariant residues are coloured dark blue while conservative substitutions are depicted in shades of light blue. (B) Left, Crystal structure of the MARF1 NYN domain shown in cartoon and surface representations. Right, cartoon representation of the MARF1 NYN domain, with invariant active site residues depicted in stick format. (C) Structural superpositions of the human MARF1 NYN domain with the NYN domain of Bacillus subtilis YacP/Rae1 (PDB 5MQ8), and the PIN domains of human SMG6 (PDB 2HWW) and MCPIP1 (PDB 3V34). The structures were superimposed using the DALI server (51) and are shown in identical orientations. (D) Zoom-in view of the NYN domain ribonuclease active site of MARF1, overlaid with the structures of human SMG6 and MCPIP1 PIN domains. Invariant active site residues are shown in stick format. The bound magnesium ion present in the MCPIP1 structure is depicted as a purple sphere.
Figure 4. Structure of the MARF1 NYN domain. (A) Comparative sequence analysis of the NYN domains of human (Hs), Xenopus tropicalis (Xt), Danio rerio (Dr), Lasius niger (Ha) and Apis mellifera (Am) MARF1 orthologs. The multiple sequence alignment was generated using MAFFT version 7 and formatted using Jalview (49,50). Secondary structure elements with corresponding numbering are indicated above the sequence. Invariant residues are coloured dark blue while conservative substitutions are depicted in shades of light blue. (B) Left, Crystal structure of the MARF1 NYN domain shown in cartoon and surface representations. Right, cartoon representation of the MARF1 NYN domain, with invariant active site residues depicted in stick format. (C) Structural superpositions of the human MARF1 NYN domain with the NYN domain of Bacillus subtilis YacP/Rae1 (PDB 5MQ8), and the PIN domains of human SMG6 (PDB 2HWW) and MCPIP1 (PDB 3V34). The structures were superimposed using the DALI server (51) and are shown in identical orientations. (D) Zoom-in view of the NYN domain ribonuclease active site of MARF1, overlaid with the structures of human SMG6 and MCPIP1 PIN domains. Invariant active site residues are shown in stick format. The bound magnesium ion present in the MCPIP1 structure is depicted as a purple sphere.CC BY · PubMed Central
Figure 5. The MARF1 NYN displays endoribonuclease activity in vitro. (A) Upper panel: Schematic representation of the wild-type and mutant (MUT) MARF1 NYN proteins used for in vitro degradation assays. Mutant MARF1 protein contains tandem alanine substitutions for Asp426 and Asp427. Lower panel: Coomassie-stained SDS-PAGE gel of recombinant wild-type (WT) or mutant (MUT) MARF1 NYN proteins. (B) NYNWT protein was incubated with a 5′-32P-end-labelled U30 oligonucleotide in the presence or absence of 3 mM Mn2+ or Mg2+. RNA was extracted at defined time points and resolved via denaturing PAGE. RNA signals were visualized by autoradiography. OH: hydrolysis ladder. (C) Time course analysis of NYNWT and NYNMUT proteins incubated with a 5′-32P-end-labelled U30 oligonucleotide in the presence of Mn2+. OH: hydrolysis ladder. (D) NYNWT protein was incubated in the presence of Mn2+ with a 3′-32P-end-labelled U30 oligonucleotide. RNA was extracted at defined time points and resolved via denaturing PAGE. OH: hydrolysis ladder.
Figure 5. The MARF1 NYN displays endoribonuclease activity in vitro. (A) Upper panel: Schematic representation of the wild-type and mutant (MUT) MARF1 NYN proteins used for in vitro degradation assays. Mutant MARF1 protein contains tandem alanine substitutions for Asp426 and Asp427. Lower panel: Coomassie-stained SDS-PAGE gel of recombinant wild-type (WT) or mutant (MUT) MARF1 NYN proteins. (B) NYNWT protein was incubated with a 5′-32P-end-labelled U30 oligonucleotide in the presence or absence of 3 mM Mn2+ or Mg2+. RNA was extracted at defined time points and resolved via denaturing PAGE. RNA signals were visualized by autoradiography. OH: hydrolysis ladder. (C) Time course analysis of NYNWT and NYNMUT proteins incubated with a 5′-32P-end-labelled U30 oligonucleotide in the presence of Mn2+. OH: hydrolysis ladder. (D) NYNWT protein was incubated in the presence of Mn2+ with a 3′-32P-end-labelled U30 oligonucleotide. RNA was extracted at defined time points and resolved via denaturing PAGE. OH: hydrolysis ladder.CC BY · PubMed Central
Figure 6. MARF1 NYN displays endonuclease activity in vivo. (A and E) Expression levels of λNHA-tagged fusion proteins, as determined by Western analysis using anti-HA and anti-actin antibodies. (B) RL activity detected in extracts from HeLa cells expressing the indicated proteins. Cells were cotransfected with constructs expressing the RL-5BoxB reporter, FL, and indicated fusion proteins. Histograms represented normalized mean values of RL activity and mRNA levels from a minimum of three experiments. RL activity values seen in the presence of λNHA-LacZ were set as 100. (C) Representative Northern blot of RL-5BoxB and FL mRNAs levels for (B). (D) Schematic diagram of the Renilla luciferase-encoding mRNA reporter, containing five 19-nt BoxB hairpins, a 114 nt internal poly(A), a 40 nt linker and a self-cleaving hammerhead ribozyme (HHR). HHR cleavage site is denoted by an arrow. (F) Cells were cotransfected with constructs expressing the RL-5BoxB-A114-N40-HHR reporter, FL, and indicated fusion proteins. Histograms represented normalized mean values of RL activity and mRNA levels from a minimum of three experiments. RL activity values seen in the presence of λNHA-LacZ were set as 100. (G) Representative Northern blot of RL-5BoxB-A114-N40-HHR and FL mRNAs levels for (F).
Figure 6. MARF1 NYN displays endonuclease activity in vivo. (A and E) Expression levels of λNHA-tagged fusion proteins, as determined by Western analysis using anti-HA and anti-actin antibodies. (B) RL activity detected in extracts from HeLa cells expressing the indicated proteins. Cells were cotransfected with constructs expressing the RL-5BoxB reporter, FL, and indicated fusion proteins. Histograms represented normalized mean values of RL activity and mRNA levels from a minimum of three experiments. RL activity values seen in the presence of λNHA-LacZ were set as 100. (C) Representative Northern blot of RL-5BoxB and FL mRNAs levels for (B). (D) Schematic diagram of the Renilla luciferase-encoding mRNA reporter, containing five 19-nt BoxB hairpins, a 114 nt internal poly(A), a 40 nt linker and a self-cleaving hammerhead ribozyme (HHR). HHR cleavage site is denoted by an arrow. (F) Cells were cotransfected with constructs expressing the RL-5BoxB-A114-N40-HHR reporter, FL, and indicated fusion proteins. Histograms represented normalized mean values of RL activity and mRNA levels from a minimum of three experiments. RL activity values seen in the presence of λNHA-LacZ were set as 100. (G) Representative Northern blot of RL-5BoxB-A114-N40-HHR and FL mRNAs levels for (F).CC BY · PubMed Central
Figure 7. Model of MARF1-mediated mRNA decay. MARF1 binds to a target mRNA via its RRMs. The MARF1 NYN endonuclease cleaves the target mRNA, which is subsequently decapped by the DCP1:DCP2 complex and degraded by XRN1 (not shown). Of note, MARF1-binding sites on targeted mRNAs have yet to be experimentally validated.
Figure 7. Model of MARF1-mediated mRNA decay. MARF1 binds to a target mRNA via its RRMs. The MARF1 NYN endonuclease cleaves the target mRNA, which is subsequently decapped by the DCP1:DCP2 complex and degraded by XRN1 (not shown). Of note, MARF1-binding sites on targeted mRNAs have yet to be experimentally validated.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 53 references

Research works printed but not linked: 1

  1. Kabsch, 2010, Xds, Acta Crystallogr. D. Biol. Crystallogr., 66, 125

Cited by

See all 31

Metadata

Authors
Nishimura, T., Fakim, H., Brandmann, T., Youn, J.-Y., Gingras, A.-C., Jinek, M., & Fabian, M. R.
Affiliations
  • Jewish General Hospital (CA)
  • University of Zurich (CH)
  • Lunenfeld-Tanenbaum Research Institute (CA)
  • University of Toronto (CA)
  • Department of Biochemistry, University of Zurich, Switzerland
Corresponding author
Fabian, Marc R
Venue
Nucleic Acids Research
Published
2018-10-26
Volume
46
Issue
22
Pages
12008-12021
ISSN
  • 0305-1048 (ISSN-L)
  • 1362-4962
OpenAlex
W2898159486
Cited by
31
References
53
Citations by year
2026: 3 · 2025: 1 · 2024: 4 · 2023: 5 · 2022: 4 · 2021: 3 · 2020: 8 · 2019: 3
FWCI
1.25
Type
journal article
Language
en
Open access
Locations
  • Nucleic Acids Research (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
  • DORA PSI (Paul Scherrer Institute) (submittedVersion, other-oa)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
  • Canadian Institutes of Health Research (MOP-130425)
  • Natural Sciences and Engineering Research Council of Canada (RGPIN-2015-03712, RGPIN-2014-06434)
  • European Research Council (ERC-StG-337284)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
Keywords
endoribonuclease, mRNA decapping, post-transcriptional gene silencing, crystal structure, RNA-binding proteins, retrotransposon expression, RRM domain
MeSH terms
Protein Conformation, alpha-Helical, Protein Conformation, beta-Strand, Amino Acid Sequence, Animals, Binding Sites, Endoribonucleases, Escherichia coli, HeLa Cells, Humans, Models, Molecular, Protein Binding, Recombinant Proteins, RNA, Messenger, Trans-Activators, Gene Expression, Sequence Homology, Amino Acid, Crystallography, X-Ray, Cell Cycle Proteins, Protein Isoforms, RNA Interference, Mice, Protein Interaction Domains and Motifs, HEK293 Cells, RNA Cleavage

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human MARF1 is an endoribonuclease that interacts with the DCP1:2 decapping complex and degrades target mRNAs. https://app.cochat.ai/papers/10.1093/nar/gky1011
The paper
Nishimura, T., Fakim, H., Brandmann, T., Youn, J.-Y., Gingras, A.-C., Jinek, M., & Fabian, M. R. (2018). Human MARF1 is an endoribonuclease that interacts with the DCP1:2 decapping complex and degrades target mRNAs. Nucleic Acids Research. https://doi.org/10.1093/nar/gky1011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.